Skip to content
lifestyle.side.cr
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Lakefront Biotherapeutics
U.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus
August 24, 2026
Lakefront Receives Transparency Notification from Bank of America
August 24, 2026
Acquisition of Own Shares
August 18, 2026
Acquisition of Own Shares
August 12, 2026
Lakefront Biotherapeutics Reports Half-Year 2026 Financial Results and Provides Business Update
August 10, 2026
Acquisition of Own Shares
August 4, 2026
Acquisition of Own Shares
July 28, 2026
Lakefront Announces Initiation of €50 Million Stock Repurchase Program
June 9, 2026
Lakefront Appoints Eric Hedrick, MD, as Chief Medical Officer
June 8, 2026
GILEAD SCIENCES AND LAKEFRONT COMPLETE ACQUISITION OF OURO MEDICINES TO FURTHER EXPAND INFLAMMATION PIPELINE
June 4, 2026
1
2
Next Page
→